Cite
HARVARD Citation
Hawks, M. et al. (2017). Is rivaroxaban a cost‐effective anticoagulation therapy compared with warfarin?. Evidence-based practice. 20 (10), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hawks, M. et al. (2017). Is rivaroxaban a cost‐effective anticoagulation therapy compared with warfarin?. Evidence-based practice. 20 (10), p. . [Online].